Itraconazole and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Itraconazole (itraconazole) and Humalog (insulin lispro recombinant). Common drug interactions include cough among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Itraconazole and Humalog. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Itraconazole?

Itraconazole has active ingredients of itraconazole. It is often used in fungal infection. eHealthMe is studying from 12,372 Itraconazole users. Check the latest studies of Itraconazole.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

On Jul, 13, 2026

59 people who take Itraconazole and Humalog together, and have interactions are studied.

Itraconazole and Humalog drug interactions.

What are the common drug interactions of Itraconazole and Humalog, by gender? *:

female:

Cough
Dyspnoea (difficult or laboured respiration)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Infection
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pyrexia (fever)
Abdominal pain
Asthma
Blood beta-d-glucan increased
Blood pressure decreased

male:

Pyrexia (fever)
Anaemia (lack of blood)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Forced expiratory volume decreased (decreased lung expired air volume)
Glycosylated haemoglobin increased
Lower respiratory tract infection
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Vital capacity decreased
Hyperkalaemia (damage to or disease of the kidney)
Asthma

What are the common drug interactions of Itraconazole and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood creatine phosphokinase increased
Infection
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

20-29:

Lung transplant
Herpes zoster
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)
Forced expiratory volume decreased (decreased lung expired air volume)
Glycosylated haemoglobin increased
Lower respiratory tract infection
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Vital capacity decreased
Asthma
Allergic respiratory disease
Blood immunoglobulin e increased
Dyspnoea (difficult or laboured respiration)

40-49:

Cerebral aspergillosis (pus collection with swelling in brain)
Diffuse alveolar damage (common manifestation of drug-induced lung injury)
Neutropenia (an abnormally low number of neutrophils)
Pleural effusion (water on the lungs)
Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
Secondary immunodeficiency (lack of immunity due to some disease)
Sepsis (a severe blood infection that can lead to organ failure and death)
Cerebral haemorrhage (bleeding within the brain)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)

50-59:

Cardiac failure congestive
Fall
Hyperkalaemia (damage to or disease of the kidney)
Lethargy (tiredness)
Renal failure acute (rapid kidney dysfunction)
Cystic fibrosis (disease of the secretary glands)
Infection
Lung transplant rejection (failure of lung transplant)
Visual disturbance
Headache (pain in head)

60+:

Pyrexia (fever)
Anaemia (lack of blood)
Candida pneumonia (infection of lung by candida)
Dehydration (dryness resulting from the removal of water)
Enterobacter pneumonia (lung inflammation caused by bacteria of the family enterobacteriaceae)
Faecal incontinence (a lack of control over passing stool)
Flushing (the warm, red condition of human skin)
Hyperkalaemia (damage to or disease of the kidney)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 15.25%
Cystic Fibrosis (disease of the secretary glands): 9 people, 15.25%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 13.56%
Asthma: 7 people, 11.86%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 10.17%
Bronchopulmonary Aspergillosis Allergic (allergic lung disorder caused by aspergillus fungi): 6 people, 10.17%
Dyspnea (difficult or laboured breathing): 5 people, 8.47%
Pain: 4 people, 6.78%
Nausea (feeling of having an urge to vomit): 4 people, 6.78%
Hyperkalemia (damage to or disease of the kidney): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Itraconazole and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously